SETTLEMENT AGREEMENT, RELEASE AND AMENDMENT TO LDASettlement Agreement, Release and Amendment • December 20th, 2021 • Alvotech Lux Holdings S.A.S. • New York
This Settlement Agreement, Release and Amendment to LDA (this “Agreement”) is entered into as of June 28, 2021 (the “Amendment Effective Date”) by and between Teva Pharmaceuticals International GmbH, a company organized under the laws of Switzerland, having its principal place of business at Schluselstrasse 12, Rapperswil–Jona 8645, Switzerland (“Teva”), and Alvotech Hf., a corporation organized under the laws of Iceland, having its principal place of business at Saemundargotu 15-19, 101, Reykjavik, Iceland (“Alvotech”). Teva and Alvotech shall be referred to collectively as the “Parties” and individually as a “Party.”
